2 recruiting, 1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Stage II Hypopharyngeal Carcinoma AJCC v8: new trials by email Literature Review of Stage II Hypopharyngeal Carcinoma AJCC v8 trials Research Report on Stage II Hypopharyngeal Carcinoma AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Best Practice, Biospecimen Collection, Cisplatin - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Recruiting | NRG Oncology | 98 | 2025-06-23 | 2026-08-17 |
| A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation Best Practice, Consensus Auditory-Perceptual Evaluation of Voice, Diagnostic Imaging - Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal Carcinoma | Not applicable | Withdrawn | Mayo Clinic | 2022-12-01 | 2023-01-06 | |
| Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer Proton Beam Radiation Therapy, Quality-of-Life Assessment, Questionnaire Administration - Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hypopharyngeal Squamous Cell Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 3 | 2020-10-19 | 2024-10-29 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer Biospecimen Collection, Questionnaire Administration - Carcinoma of Unknown Primary, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Recruiting | M.D. Anderson Cancer Center | 471 | 2016-12-29 | 2026-10-06 |
Carcinoma (4) · Hypopharyngeal Neoplasms (4) · Laryngeal Neoplasms (4) · Nasopharyngeal Carcinoma (3) · Oropharyngeal Neoplasms (3) · Mouth Neoplasms (2) · Neoplasms, Unknown Primary (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomatitis (1)
Head and Neck Neoplasms (4) · Laryngeal Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Otorhinolaryngologic Diseases (4) · Otorhinolaryngologic Neoplasms (4) · Pharyngeal Diseases (4) · Pharyngeal Neoplasms (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Stomatognathic Diseases (4) · Nasopharyngeal Diseases (3) · Nasopharyngeal Neoplasms (3)
Practice Guidelines as Topic (2) · Standard of Care (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Drug Delivery Systems (1) · Magnetic Resonance Spectroscopy (1) · Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin (1) · Platinum (1) · Proton Therapy (1) · Protons (1) · Radiotherapy, Image-Guided (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1) · X-Rays (1)
M.D. Anderson Cancer Center (2) · Mayo Clinic (1) · NRG Oncology (1)
United States (3)
Clifton D Fuller (1) · David M Brizel (1) · Eileen H Shinn (1) · Lisa Crujido (1)
R21DE019954 (1), UG1CA189867 (1)